Aurobindo Pharma Limited in India had a heavy focus on their cardiovascular abbreviated new drug applications with almost 25 percent of market size in financial year 2019. Their anti-diabetic drugs came second with over nine percent of market size that year.
Market size of Aurobindo Pharma Limited's abbreviated new drug applications in financial year 2019, by therapy (in billion U.S dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's ANDA filings FY 2019, by therapy
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Premium Statistic Aurobindo Pharma's net profit FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue FY 2013-2023
About the region
10
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' net worth FY 2014-2023
Selected statistics
1
Other regions
9
- Premium Statistic Sawai Group's net income FY 2013-2022
- Premium Statistic Total drug prescriptions dispensed in the U.S. 2009-2022
- Premium Statistic Sales of pharmaceutical drugs Thailand 2021, by type
- Basic Statistic Top indications for new brand drug approvals in Canada in 2018
- Premium Statistic Dr. Reddy's Laboratories' revenue from global generics 2022 by region
- Basic Statistic Share value of the generic pharmaceuticals market in Finland 2012-2021
- Basic Statistic Value of pharmaceutical sales in Ireland 2010-2021
- Basic Statistic Value of pharmaceutical sales in Austria 2012-2021
- Basic Statistic Value of pharmaceutical sales in Luxembourg 2003-2022
Related statistics
10
- Premium Statistic R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021
- Premium Statistic MAT of therapies in Indian pharma 2022
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
- Premium Statistic Growth rate of top therapies in Indian pharmaceuticals 2022
- Premium Statistic Sun Pharma's revenue India 2022, by leading therapy drug
- Premium Statistic Sun Pharma's market share of therapy drugs India 2022
- Premium Statistic Revenue Cadila Healthcare India 2022, by leading therapy drug
- Premium Statistic Growth rate of therapy drugs by Cadila Healthcare India 2022
- Premium Statistic Alembic Pharma India revenue 2022, by leading therapy drug
- Premium Statistic Number of Indian ANDA approvals by the U.S. FDA 2017-2019
Further related statistics
10
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Kellogg's net sales worldwide 2009-2022, by regional segment
- Kellogg Company's net sales worldwide 2004-2022
- International Paper's revenue 2010-2023
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
Further Content: You might find this interesting as well
Statistics
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Kellogg's net sales worldwide 2009-2022, by regional segment
- Kellogg Company's net sales worldwide 2004-2022
- International Paper's revenue 2010-2023
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
Aurobindo Pharma. (August 2, 2019). Market size of Aurobindo Pharma Limited's abbreviated new drug applications in financial year 2019, by therapy (in billion U.S dollars) [Graph]. In Statista. Retrieved March 28, 2024, from https://www.statista.com/statistics/996043/india-aurobindo-pharma-market-size-new-drug-applications/
Aurobindo Pharma. "Market size of Aurobindo Pharma Limited's abbreviated new drug applications in financial year 2019, by therapy (in billion U.S dollars)." Chart. August 2, 2019. Statista. Accessed March 28, 2024. https://www.statista.com/statistics/996043/india-aurobindo-pharma-market-size-new-drug-applications/
Aurobindo Pharma. (2019). Market size of Aurobindo Pharma Limited's abbreviated new drug applications in financial year 2019, by therapy (in billion U.S dollars). Statista. Statista Inc.. Accessed: March 28, 2024. https://www.statista.com/statistics/996043/india-aurobindo-pharma-market-size-new-drug-applications/
Aurobindo Pharma. "Market Size of Aurobindo Pharma Limited's Abbreviated New Drug Applications in Financial Year 2019, by Therapy (in Billion U.S Dollars)." Statista, Statista Inc., 2 Aug 2019, https://www.statista.com/statistics/996043/india-aurobindo-pharma-market-size-new-drug-applications/
Aurobindo Pharma, Market size of Aurobindo Pharma Limited's abbreviated new drug applications in financial year 2019, by therapy (in billion U.S dollars) Statista, https://www.statista.com/statistics/996043/india-aurobindo-pharma-market-size-new-drug-applications/ (last visited March 28, 2024)
Market size of Aurobindo Pharma Limited's abbreviated new drug applications in financial year 2019, by therapy (in billion U.S dollars) [Graph], Aurobindo Pharma, August 2, 2019. [Online]. Available: https://www.statista.com/statistics/996043/india-aurobindo-pharma-market-size-new-drug-applications/